Trial intelligence / Profile preview

Methotrexate vs Methotrexate/Actinomycin-D in Low-Risk Gestational Trophoblastic Neoplasia

NCT01823315Phase 3Unknown

Start
Dec 2012
Primary completion
Dec 2015
Modality
DNA Intercalators/Alkylators, Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methotrexate, actinomycin D in gestational trophoblastic neoplasia (GTN). Status: unknown.

02

Drugs

methotrexateactinomycin D
03

Conditions

gestational trophoblastic neoplasia (GTN)

Beyond the preview

Go deeper on NCT01823315.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01823315.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call